The potyviral silencing suppressor HCPro recruits and employs host ARGONAUTE1 in pro-viral functions

PLoS Pathog. 2020 Oct 8;16(10):e1008965. doi: 10.1371/journal.ppat.1008965. eCollection 2020 Oct.

Abstract

In this study, we demonstrate a novel pro-viral role for the Nicotiana benthamiana ARGONAUTE 1 (AGO1) in potyvirus infection. AGO1 strongly enhanced potato virus A (PVA) particle production and benefited the infection when supplied in excess. We subsequently identified the potyviral silencing suppressor, helper-component protease (HCPro), as the recruiter of host AGO1. After the identification of a conserved AGO1-binding GW/WG motif in potyviral HCPros, we used site-directed mutagenesis to introduce a tryptophan-to-alanine change into the HCPro (HCProAG) of PVA (PVAAG) and turnip mosaic virus (TuMVAG). AGO1 co-localization and co-immunoprecipitation with PVA HCPro was significantly reduced by the mutation suggesting the interaction was compromised. Although the mutation did not interfere with HCPro's complementation or silencing suppression capacity, it nevertheless impaired virus particle accumulation and the systemic spread of both PVA and TuMV. Furthermore, we found that the HCPro-AGO1 interaction was important for AGO1's association with the PVA coat protein. The coat protein was also more stable in wild type PVA infection than in PVAAG infection. Based on these findings we suggest that potyviral HCPro recruits host AGO1 through its WG motif and engages AGO1 in the production of stable virus particles, which are required for an efficient systemic infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Mutation
  • Nicotiana / genetics
  • Nicotiana / metabolism
  • Nicotiana / virology*
  • Plant Diseases / virology*
  • Plant Proteins / genetics
  • Plant Proteins / metabolism*
  • Potyvirus / physiology*
  • RNA Interference*
  • Viral Proteins / genetics
  • Viral Proteins / metabolism*

Substances

  • Plant Proteins
  • Viral Proteins

Supplementary concepts

  • Potato virus A

Grants and funding

This work supported by grants from Jane and Aatos Erkko Foundation (no. 4704372) and Academy of Finland (no. 298254) to K.M. ERASMUS MUNDUS Brave program supported the work of S.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.